SLC25A1P5

Across TCGA pan-cancer cohorts, SLC25A1P5 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated SLC25A1P5 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher SLC25A1P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SLC25A1P5 expression acts as an unfavorable survival marker, although some lineages such as PAAD and ESCA show a favorable association.

MESO, PAAD, and KIRC are the cancer types where SLC25A1P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Quartile	All	0.199	0.475	<.001	51	view →
PAAD	OS	Median	All	0.605	0.294	<.001	41	view →
KIRC	DFS	Quartile	All	0.499	0.703	.007	35	view →
LIHC	DFS	Quartile	All	0.396	0.595	<.001	32	view →
LGG	DFS	Tertile	All	0.661	0.815	<.001	30	view →
READ	DFS	Median	All	0.375	0.758	<.001	27	view →
KICH	DFS	Quartile	All	0.660	1.000	.006	25	view →
OV	OS	Quartile	III,IV	0.627	0.743	.003	24	view →
LUSC	OS	Tertile	II,III,IV	0.303	0.616	.018	18	view →
ACC	DFS	Tertile	All	0.528	0.768	.006	12	view →
ESCA	DFS	Tertile	II,III,IV	0.547	0.385	.013	9	view →
UVM	DFS	Tertile	III,IV	0.350	0.745	.008	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

SLC25A1P5–MESO (DFS)

Open the MESO breakdown →